Susquehanna International Group, LLP Champions Oncology, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$4.56 - $6.59 $6,383 - $9,226	-1,400 Reduced 10.45%	12,000 $67,000
Q3 2023 Nov 14, 2023	BUY	$5.2 - $7.32 $69,680 - $98,088	13,400 New	13,400 $83,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $9.47 $56,959 - $74,813	7,900 Added 13.88%	64,800 $486,000
Q2 2022 Aug 15, 2022	BUY	$6.81 - $8.31 $138,924 - $169,524	20,400 Added 55.89%	56,900 $460,000
Q1 2022 May 16, 2022	BUY	$7.26 - $8.53 $264,990 - $311,345	36,500 New	36,500 $297,000

5.82M

15K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $61.1M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.